| Symbol: |
CRYBG3
|
| Description: |
beta-gamma crystallin domain containing 3 [Source:HGNC Symbol;Acc:34427]
|
| Location: |
Chr3:97595819-97663810[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:209
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| CRYBG3 |
6,7-dimethyl-1,4-di-N-oxide-3-methylquinoxalin-2-yl-4-(4-nit rophenyl)piperazinyl ketone |
0.006 |
Down |
| CRYBG3 |
3'-C-ethinylcytidine |
0.029 |
Up |
| CRYBG3 |
NSC 723548 |
0.044 |
Up |
| CRYBG3 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.023 |
Up |
| CRYBG3 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.028 |
Up |
| CRYBG3 |
NSC 726260 |
0.02 |
Up |
| CRYBG3 |
NSC 726373 |
0.023 |
Down |
| CRYBG3 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.021 |
Up |
| CRYBG3 |
Everolimus |
0.033 |
Down |
| CRYBG3 |
NSC 734385 |
0.029 |
Up |
| CRYBG3 |
NSC 734631 |
0.028 |
Up |
| CRYBG3 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.03 |
Down |
| CRYBG3 |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.003 |
Up |
| CRYBG3 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.031 |
Up |
| CRYBG3 |
6-(3-Aminopropyl)-5,6-dihyro-9-iodo-3-nitro-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline Hydrochloride |
0.035 |
Up |
Expression pattern: Sensitivity / Resistance
Total:14 Current:13
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:18
Total:2 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|